DNMT3B and B-cell non-Hodgkin lymphoma: DNMT3B likely plays a role in pathogenesis of various hematologic malignancies as genetic alterations were identified in cutaneous T-cell lymphomas (CTCLs) and B-cell lymphomas (BCLs) (23, 24).